Stocks · Health care · Surgical & Medical Instruments & Apparatus

NeuroPace Inc

NPCE Clue Score46
United States Fiscal year ends December CIK 0001528287
$12.67 +2.26% Close, 9 Oct 2026
Price $12.67 −23.49% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 22 Apr 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue41.1Operating income−13.1Net income−24.3EPS, diluted−117.85Fiscal year 2021Revenue45.2 +9.8%Operating income−23.7Net income−36.1EPS, diluted−2.17Fiscal year 2022Revenue45.5 +0.7%Operating income−40.8Net income−47.1EPS, diluted−1.91Fiscal year 2023Revenue65.4 +43.7%Operating income−27.2Net income−33.0EPS, diluted−1.27Fiscal year 2024Revenue79.9 +22.1%Operating income−21.7Net income−27.1EPS, diluted−0.93Fiscal year 2025Revenue100.0 +25.1%Operating income−16.3Net income−21.5EPS, diluted−0.66
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 41.1 45.2 45.5 65.4 79.9 100.0
Growth +9.8% +0.7% +43.7% +22.1% +25.1%
Operating income −13.1 −23.7 −40.8 −27.2 −21.7 −16.3
Net income −24.3 −36.1 −47.1 −33.0 −27.1 −21.5
Growth
EPS, diluted −117.85 −2.17 −1.91 −1.27 −0.93 −0.66

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2020Gross margin73.6%Operating margin−31.7%Net margin−59.0%Free cash flow margin−52.7%Fiscal year 2021Gross margin74.0%Operating margin−52.5%Net margin−79.9%Free cash flow margin−55.2%Fiscal year 2022Gross margin71.4%Operating margin−89.6%Net margin−103.4%Free cash flow margin−82.3%Fiscal year 2023Gross margin73.6%Operating margin−41.5%Net margin−50.4%Free cash flow margin−30.4%Fiscal year 2024Gross margin73.9%Operating margin−27.1%Net margin−34.0%Free cash flow margin−22.8%Fiscal year 2025Gross margin77.2%Operating margin−16.3%Net margin−21.5%Free cash flow margin−11.3%
FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 73.6% 74.0% 71.4% 73.6% 73.9% 77.2%
Operating margin −31.7% −52.5% −89.6% −41.5% −27.1% −16.3%
Net margin −59.0% −79.9% −103.4% −50.4% −34.0% −21.5%
Free cash flow margin −52.7% −55.2% −82.3% −30.4% −22.8% −11.3%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−21.6Capital expenditure−0.1Free cash flow−21.7Fiscal year 2021Operating cash flow−24.6Capital expenditure−0.4Free cash flow−25.0Fiscal year 2022Operating cash flow−36.9Capital expenditure−0.6Free cash flow−37.5Fiscal year 2023Operating cash flow−19.7Capital expenditure−0.2Free cash flow−19.9Fiscal year 2024Operating cash flow−17.9Capital expenditure−0.3Free cash flow−18.3Buybacks0.0Fiscal year 2025Operating cash flow−11.0Capital expenditure−0.3Free cash flow−11.3Buybacks−49.5
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −21.6 −24.6 −36.9 −19.7 −17.9 −11.0
Capital expenditure −0.1 −0.4 −0.6 −0.2 −0.3 −0.3
Free cash flow −21.7 −25.0 −37.5 −19.9 −18.3 −11.3
Growth
Buybacks n/a n/a n/a n/a 0.0 −49.5

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2020Cash26.4Total debt52.9Net cash (debt)−26.5Shareholders’ equity−147.8Fiscal year 2021Cash19.2Total debt49.8Net cash (debt)−30.7Shareholders’ equity73.5Debt to equity0.68Fiscal year 2022Cash6.6Total debt52.9Net cash (debt)−46.3Shareholders’ equity34.8Debt to equity1.52Fiscal year 2023Cash18.1Total debt57.0Net cash (debt)−38.9Shareholders’ equity20.7Debt to equity2.76Fiscal year 2024Cash13.4Total debt59.5Net cash (debt)−46.1Shareholders’ equity8.0Debt to equity7.43Fiscal year 2025Cash21.7Total debt58.9Net cash (debt)−37.2Shareholders’ equity19.0Debt to equity3.09
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 26.4 19.2 6.6 18.1 13.4 21.7
Total debt 52.9 49.8 52.9 57.0 59.5 58.9
Net cash (debt) −26.5 −30.7 −46.3 −38.9 −46.1 −37.2
Shareholders’ equity −147.8 73.5 34.8 20.7 8.0 19.0
Debt to equity n/a 0.68 1.52 2.76 7.43 3.09

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
26.4 19.2 6.6 18.1 13.4 21.7
8.4 7.1 7.5 12.3 12.9 14.7
6.9 7.8 9.7 11.2 13.4 16.9
0.5 0.6 1.1 1.0 1.1 1.1
56.0 133.6 114.1 107.7 94.6 105.6
Growth +138.7% −14.6% −5.7% −12.1% +11.5%
Liabilities
2.0 0.0 n/a n/a n/a n/a
50.8 49.8 52.9 57.0 59.5 58.9
calc 52.9 49.8 52.9 57.0 59.5 58.9
62.4 60.1 79.3 87.0 86.6 86.5
Equity
−387.7 −423.8 −470.9 −503.8 −531.0 −552.4
−147.8 73.5 34.8 20.7 8.0 19.0
Growth −52.7% −40.6% −61.2% +137.5%
Per share and net cash
calc −26.5 −30.7 −46.3 −38.9 −46.1 −37.2
0.3 24.5 25.0 27.8 30.1 33.6
calc −470.66 3.01 1.39 0.74 0.27 0.57

† The diluted share count jumps at 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how.